1st Quarter - Report

BROWN RUDNICK LLP for PRIME THERAPEUTICS

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R. 1316-The Prescription Drug Price Transparency Act; S.637-Creating Transparency to Have Drug Rebates Unlocked Act of 2017; HR 1038 & S.413-Improving Transparency and Accuracy in Medicare Part D Drug Spending Act; Issues relating to Medicare Part D cash price disclosure

LobbyistCovered position, as disclosed
LISA LAYMAN SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)
HENRY W MENN CoS, Sen. Bob Graham (2001 - 2004); Min SD & Counsel, Cmte on Vet Affairs (2004); Sp Asst Leg Aff, FDA Office of Commissioner (1993-1995)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1038 (115th), S. 637 (115th), S. 413 (115th), H.R. 1316 (115th)

Pharmacy PHA

S.469-The Affordable and Safe Prescription Drug Importation Act

LobbyistCovered position, as disclosed
LISA LAYMAN SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)
HENRY W MENN CoS, Sen. Bob Graham (2001 - 2004); Min SD & Counsel, Cmte on Vet Affairs (2004); Sp Asst Leg Aff, FDA Office of Commissioner (1993-1995)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 469 (115th)

Health Issues HCR

HR 1628-American Health Care Act of 2017; H.R. 2051 - The FAST Generics Act; HR 749 - The Lower Drug Costs Through Competition Act; Reauthorization of the Generic Durg User Fee Act; Issues relating to biosimilars and speciality pharmacy; HR 1776 & S. 771- Improving Access to Affordable Prescription Drugs Act

LobbyistCovered position, as disclosed
LISA LAYMAN SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)
HENRY W MENN CoS, Sen. Bob Graham (2001 - 2004); Min SD & Counsel, Cmte on Vet Affairs (2004); Sp Asst Leg Aff, FDA Office of Commissioner (1993-1995)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2051 (115th), H.R. 1776 (115th), S. 771 (115th), H.R. 749 (115th), H.R. 1628 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.